XENON PHARMACEUTICALS INC. Basic Shares Outstanding (Weighted Average)
XENON PHARMACEUTICALS INC. (XENE) reported Basic Shares Outstanding (Weighted Average) of 99.61 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- XENON PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 99.61M shares, a 26.16% increase year-over-year.
- XENON PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 87.35M shares, a 11.00% increase year-over-year.
- XENON PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 80.13M shares, a 2.22% increase year-over-year.
- XENON PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 79.25M shares, a 1.70% increase year-over-year.
- XENON PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2025 was 79.25M shares, a 1.74% increase from fiscal 2024.
- XENON PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2024 was 77.89M shares, a 16.45% increase from fiscal 2023.
- XENON PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2023 was 66.89M shares, a 10.48% increase from fiscal 2022.
- XENON PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2022 was 60.54M shares, a 38.77% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 99.61M shares 10-Q · filed 2026-08-06 | 93.48M shares 10-Q · filed 2026-08-06 | 89.03M shares derived: average of 3 quarters · filed 2026-08-06 | 86.58M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 87.35M shares 10-Q · filed 2026-05-07 | 83.74M shares derived: average of 2 quarters · filed 2026-05-07 | 82.24M shares derived: average of 3 quarters · filed 2026-05-07 | 81.42M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 80.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 79.69M shares derived: average of 2 quarters · filed 2026-02-26 | 79.44M shares derived: average of 3 quarters · filed 2026-08-06 | 79.25M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 79.25M shares 10-Q · filed 2025-11-03 | 79.10M shares derived: average of 2 quarters · filed 2026-08-06 | 78.96M shares 10-Q · filed 2025-11-03 | 78.82M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 78.95M shares 10-Q · filed 2026-08-06 | 78.82M shares 10-Q · filed 2026-08-06 | 78.68M shares derived: average of 3 quarters · filed 2026-08-06 | 78.49M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 78.69M shares 10-Q · filed 2026-05-07 | 78.54M shares derived: average of 2 quarters · filed 2026-05-07 | 78.33M shares derived: average of 3 quarters · filed 2026-05-07 | 78.17M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 78.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 78.16M shares derived: average of 2 quarters · filed 2026-02-26 | 77.99M shares derived: average of 3 quarters · filed 2026-02-26 | 77.89M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 77.93M shares 10-Q · filed 2025-11-03 | 77.80M shares derived: average of 2 quarters · filed 2025-11-03 | 77.73M shares 10-Q · filed 2025-11-03 | 75.79M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 77.67M shares 10-Q · filed 2025-08-11 | 77.63M shares 10-Q · filed 2025-08-11 | 75.08M shares derived: average of 3 quarters · filed 2026-02-26 | 72.81M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 77.59M shares 10-Q · filed 2025-05-12 | 73.78M shares derived: average of 2 quarters · filed 2026-02-26 | 71.19M shares derived: average of 3 quarters · filed 2026-02-26 | 69.86M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 69.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 67.99M shares derived: average of 2 quarters · filed 2026-02-26 | 67.28M shares derived: average of 3 quarters · filed 2026-02-26 | 66.89M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 66.00M shares 10-Q · filed 2024-11-12 | 65.93M shares derived: average of 2 quarters · filed 2024-11-12 | 65.86M shares 10-Q · filed 2024-11-12 | 65.81M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 65.86M shares 10-Q · filed 2024-08-08 | 65.79M shares 10-Q · filed 2024-08-08 | 65.75M shares derived: average of 3 quarters · filed 2025-02-27 | 65.68M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 65.72M shares 10-Q · filed 2024-05-09 | 65.69M shares derived: average of 2 quarters · filed 2025-02-27 | 65.62M shares derived: average of 3 quarters · filed 2025-02-27 | 63.26M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 65.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 65.56M shares derived: average of 2 quarters · filed 2025-02-27 | 62.44M shares derived: average of 3 quarters · filed 2025-02-27 | 60.54M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 65.47M shares 10-Q · filed 2023-11-08 | 60.83M shares derived: average of 2 quarters · filed 2023-11-08 | 58.84M shares 10-Q · filed 2023-11-08 | 57.46M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 56.19M shares 10-Q · filed 2023-08-09 | 55.52M shares 10-Q · filed 2023-08-09 | 54.79M shares derived: average of 3 quarters · filed 2024-02-29 | 51.66M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 54.85M shares 10-Q · filed 2023-05-09 | 54.09M shares derived: average of 2 quarters · filed 2024-02-29 | 50.15M shares derived: average of 3 quarters · filed 2024-02-29 | 48.13M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 53.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 47.80M shares derived: average of 2 quarters · filed 2024-02-29 | 45.90M shares derived: average of 3 quarters · filed 2024-02-29 | 43.63M shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 42.27M shares 10-Q · filed 2022-11-08 | 42.18M shares derived: average of 2 quarters · filed 2022-11-08 | 40.40M shares 10-Q · filed 2022-11-08 | |
| 2021-06-30 | 42.09M shares 10-Q · filed 2022-08-09 | 39.46M shares 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | 34.54M shares 10-K · filed 2023-03-01 | |||
| 2020-06-30 | 34.98M shares 10-Q · filed 2020-08-06 | 34.08M shares 10-Q · filed 2020-08-06 | ||
| 2019-06-30 | 25.77M shares 10-Q · filed 2020-08-06 | 25.76M shares 10-Q · filed 2020-08-06 | 25.60M shares derived: average of 3 quarters · filed 2020-08-06 | 24.28M shares derived: average of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | 25.75M shares 10-Q · filed 2019-05-07 | 25.52M shares derived: average of 2 quarters · filed 2019-05-07 | 23.78M shares derived: average of 3 quarters · filed 2019-05-07 | 21.41M shares derived: average of 4 quarters · filed 2019-08-06 |
| 2018-12-31 | 25.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 22.80M shares derived: average of 2 quarters · filed 2019-03-06 | 19.97M shares derived: average of 3 quarters · filed 2019-08-06 | 19.43M shares 10-K · filed 2019-03-06 |
| 2018-09-30 | 20.31M shares 10-Q · filed 2018-11-06 | 17.31M shares derived: average of 2 quarters · filed 2019-08-06 | 17.47M shares 10-Q · filed 2018-11-06 | 17.60M shares derived: average of 4 quarters · filed 2019-08-06 |
| 2018-06-30 | 14.31M shares 10-Q · filed 2019-08-06 | 16.06M shares 10-Q · filed 2019-08-06 | 16.70M shares derived: average of 3 quarters · filed 2019-08-06 | 17.03M shares derived: average of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | 17.80M shares 10-Q · filed 2019-05-07 | 17.90M shares derived: average of 2 quarters · filed 2019-05-07 | 17.93M shares derived: average of 3 quarters · filed 2019-05-07 | 17.95M shares derived: average of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | 18.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 18.00M shares derived: average of 2 quarters · filed 2019-03-06 | 18.00M shares derived: average of 3 quarters · filed 2019-03-06 | 17.99M shares 10-K · filed 2019-03-06 |
| 2017-09-30 | 18.00M shares 10-Q · filed 2018-11-06 | 18.00M shares derived: average of 2 quarters · filed 2018-11-06 | 17.98M shares 10-Q · filed 2018-11-06 | 17.96M shares derived: average of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | 18.00M shares 10-Q · filed 2018-08-07 | 17.97M shares 10-Q · filed 2018-08-07 | 17.95M shares derived: average of 3 quarters · filed 2018-08-07 | 17.28M shares derived: average of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | 17.95M shares 10-Q · filed 2018-05-08 | 17.92M shares derived: average of 2 quarters · filed 2018-05-08 | 17.04M shares derived: average of 3 quarters · filed 2018-05-08 | 16.38M shares derived: average of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | 17.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 16.59M shares derived: average of 2 quarters · filed 2018-03-07 | 15.86M shares derived: average of 3 quarters · filed 2018-03-07 | 15.49M shares 10-K · filed 2018-03-07 |
| 2016-09-30 | 15.27M shares 10-Q · filed 2017-11-07 | 14.84M shares derived: average of 2 quarters · filed 2017-11-07 | 14.69M shares 10-Q · filed 2017-11-07 | 14.61M shares derived: average of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | 14.41M shares 10-Q · filed 2017-08-03 | 14.40M shares 10-Q · filed 2017-08-03 | 14.39M shares derived: average of 3 quarters · filed 2018-03-07 | 14.37M shares derived: average of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | 14.39M shares 10-Q · filed 2017-05-09 | 14.38M shares derived: average of 2 quarters · filed 2018-03-07 | 14.36M shares derived: average of 3 quarters · filed 2018-03-07 | 14.33M shares derived: average of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | 14.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 14.34M shares derived: average of 2 quarters · filed 2018-03-07 | 14.30M shares derived: average of 3 quarters · filed 2018-03-07 | 14.28M shares 10-K · filed 2018-03-07 |
| 2015-09-30 | 14.30M shares 10-Q · filed 2015-11-10 | 14.27M shares derived: average of 2 quarters · filed 2016-08-03 | 14.25M shares 10-Q · filed 2015-11-10 | |
| 2015-06-30 | 14.24M shares 10-Q · filed 2016-08-03 | 14.23M shares 10-Q · filed 2016-08-03 | ||
| 2014-12-31 | 8.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | 4.98M shares derived: average of 2 quarters · filed 2017-03-08 | 3.77M shares derived: average of 3 quarters · filed 2017-03-08 | 3.17M shares 10-K · filed 2017-03-08 |
| 2014-09-30 | 1.35M shares 10-Q · filed 2015-11-10 | 1.35M shares derived: average of 2 quarters · filed 2015-11-10 | 1.35M shares 10-Q · filed 2015-11-10 | |
| 2014-06-30 | 1.35M shares 10-Q · filed 2015-08-13 | 1.35M shares 10-Q · filed 2015-08-13 | ||
| 2013-12-31 | 1.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | 1.34M shares derived: average of 2 quarters · filed 2016-03-08 | 1.34M shares 10-K · filed 2016-03-08 | |
| 2013-09-30 | 1.34M shares 10-Q · filed 2014-12-15 | 1.33M shares 10-Q · filed 2014-12-15 | ||
| 2012-12-31 | 1.33M shares 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |